Dr. Gregg Silverman Archives

Tag: Dr. Gregg Silverman

The LRA Leads Exploration into the Microbiome in Lupus

January 30, 2020 Why does the immune system turn on itself to attack the body it’s supposed to protect? That question has many possible answers – and one may be the microbiome – the trillions of bacteria living inside our bodies that, in people with lupus, may trigger autoimmune attacks. An article in this week’s […] Read More

Illuminating the Microbiome’s Role in Lupus

May 15, 2019 One of the biggest questions in lupus is why the immune system tries to destroy patients’ own tissues. But in the last few years, researchers have learned that certain microbes living inside our bodies may trigger these attacks. Scientists supported by the Lupus Research Alliance (LRA) have made many of the key […] Read More

Bacteria in the Gut May be a Cause of Lupus and Flares: Shows Study Supported by Lupus Research Alliance

NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease flares in some patients, according to a new study partly funded by the Lupus Research Alliance. These findings may allow disease treatment with probiotics or diets that alter the mix of bacterial species in the intestines. […] Read More

Stelara® and Olumiant® Considered Promising by Lupus Expert

February 19, 2019 In Healio Rheumatology, Dr. Gregg Silverman, professor of medicine and pathology at NYU School of Medicine, provided an overview of potential lupus therapies in development. He highlighted ustekinumab (brand name Stelara®) and baricitinib (brand name Olumiant®) as two drugs that look particularly promising. “The phase 2 extra-renal trial of baricitinib looks good; […] Read More